Stock Analysis
- United States
- /
- Medical Equipment
- /
- NasdaqCM:AWH
Aspira Women's Health Second Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
Aspira Women's Health (NASDAQ:AWH) Second Quarter 2024 Results
Key Financial Results
- Revenue: US$2.42m (down 2.7% from 2Q 2023).
- Net loss: US$3.53m (loss widened by 52% from 2Q 2023).
- US$0.28 loss per share (further deteriorated from US$0.28 loss in 2Q 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Aspira Women's Health EPS Beats Expectations, Revenues Fall Short
Revenue missed analyst estimates by 6.8%. Earnings per share (EPS) exceeded analyst estimates by 8.2%.
Looking ahead, revenue is forecast to grow 30% p.a. on average during the next 3 years, compared to a 8.1% growth forecast for the Medical Equipment industry in the US.
Performance of the American Medical Equipment industry.
The company's shares are down 4.4% from a week ago.
Risk Analysis
What about risks? Every company has them, and we've spotted 5 warning signs for Aspira Women's Health (of which 3 can't be ignored!) you should know about.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About NasdaqCM:AWH
Aspira Women's Health
Aspira Women's Health Inc., together with its subsidiaries, discovers, develops, and commercializes of noninvasive AI-powered diagnostic tests for gynecologic diseases in the United States.